Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Viavi Solutions Inc. post-earnings release showcases growth in core networking and challenges in some segments. Click for my ...

OneMain Holdings, Inc.'s shares have performed well, but slower credit loss improvement and in-line quarterly results have ...

Apple's iPhone revenue struggles in China and wearables show softness, but potential improvements in AI and the upcoming ...

Zillow is thriving despite a challenging housing market, thanks to market share gains and improved monetization of traffic.

Discover how XPEL has achieved impressive revenue growth and stability, and know more about its future expansion plans in the ...

One Power Company seeks to raise $100 million in an IPO despite uneven revenue growth and increasing operating losses.

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

General Dynamics faces challenges in the aerospace and submarine segments, impacting performance, but growth expected, ...

Visa Inc. is a promising investment opportunity with strong financial performance, growth outlook, and potential. Click for ...

Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...

Veren Inc. plans to generate C$3.8 billion in cash flow and is focusing on growth and returning capital to shareholders.